ARCHIVES

European Commission Approves Subcutaneous Rituximab

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Beings Accelerated Review Of R01s That just Miss Payline

March 29, 1996

CDC Contribution To National Dialogue Raises Questions About Ties With ACS.

September 22, 2000

BSA, BSC Approve Concept for NCI Scholars Program

March 7, 1997

Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.

June 11, 2004

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004